Looking forward to hearing Zachary J Roberts MD PhD talk about the potential of CAR T in earlier lines of cancer treatment at the 6th Allogeneic Cell Therapies Summit on June 12. $ALLO #CART #celltherapy #immunotherapy Hanson Wade Group Learn more here: https://lnkd.in/gUxJCtSv
Allogene Therapeutics’ Post
More Relevant Posts
-
CAR-T cell therapy and antibody-drug conjugates are two promising innovative #immunotherapy approaches. Read our executive summary to learn how these treatments are working to revolutionize cancer treatment. https://ow.ly/pm8f50QvA4B #CASInsights #drugdiscovery
R&D Insight: Unique views into immuno-oncology
To view or add a comment, sign in
-
Treatment for an aggressive form of myeloma could improve after scientists uncovered new insights into how a class of enzymes and its epigenetic target can make the blood cancer aggressive and resistant to treatment. Read the latest #BSHNews story here: https://ow.ly/kjkJ50PMFu6
To view or add a comment, sign in
-
-
Discover the power of Curcumin in inhibiting cancer growth and boosting cell death through multiple pathways, including antioxidant activity, tumor suppression, and enhancing chemotherapy effects. While promising, ongoing research is crucial to unlock its full potential in cancer treatment. #Curcumin #CancerResearch #ChemotherapyEnhancement
To view or add a comment, sign in
-
-
"Specialist Medical Oncologist, DHA &MOH Eligibity 🇦🇪🇸🇾, ESMO Member, and Collaborator Extraordinaire - Let's Connect on Telegram and DM for Inspiring Partnerships!"
#prostatecancer Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN #Study ❓Is there any effect of previous local therapy on the response to Apalutamide in pts with mHSPC? 🎯 YES! Pts who underwent local therapy had better OS after adjusting for confounding factors! (such as stage at diagnosis) full text in the comment
To view or add a comment, sign in
-
-
Leading Chief Pharmaceutical Officer | Regulatory Strategy, Clinical Development, Quality Assurance, Pharmacovigilance, Medical Device Regulation
𝐏𝐫𝐨𝐦𝐢𝐬𝐢𝐧𝐠 𝐀𝐧𝐭𝐢-𝐂𝐚𝐧𝐜𝐞𝐫 𝐃𝐫𝐮𝐠 𝐒𝐡𝐨𝐰𝐬 𝐈𝐧𝐜𝐫𝐞𝐝𝐢𝐛𝐥𝐞 𝐑𝐞𝐬𝐮𝐥𝐭𝐬 𝐢𝐧 𝐇𝐮𝐦𝐚𝐧 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬: PAC-1, a drug originally developed by scientists at the University of Illinois Urbana-Champaign, triggers programmed cell death in cancer cells. #cancer #therapy #innovation #PAC-1
Promising Anti-Cancer Drug Shows Incredible Results in Human Clinical Trials
thebrighterside.news
To view or add a comment, sign in
-
Enzalutamide improves outcomes in in biochemically recurrent prostate cancer https://lnkd.in/eTmWbg7A
To view or add a comment, sign in
-
-
A #meta_analysis assessed deregulated genes involved in relapse of #ovarian_cancer after first-line treatment with #cisplatin. Regulators of PI3K/AKT signaling pathway, ion channels, and cell adhesion proteins orchestrate #cisplatin_resistance development in ovarian cancer. Find out more: https://lnkd.in/dhJJMQP9 #CancerReports #Wiley #OpenAccess
To view or add a comment, sign in
-
Discover the impact of HMTs & KDMs on cancer progression and targeted therapies. Explore the challenges in studying these changes and how EpigenTek's assays can help. #epigenetics 👉https://lnkd.in/ePEgid3j
To view or add a comment, sign in
-
Enzalutamide improves outcomes in in biochemically recurrent prostate cancer https://lnkd.in/eTmWbg7A
To view or add a comment, sign in
-